This February, we join the global community in recognizing World Cancer Day, a time to unite and amplify our commitment…

Advancement in product development, accelerated market entry and exhibitions: In 2024, Uniogen experienced an exceptional year marked by significant progress…

In August the company was accepted into the AMPlify program (an accelerated market entry platform), which is organized in collaboration…

Kaisa Huhtinen, Uniogen´s Oncology Clinical Manager, has a deep understanding of ovarian cancer diagnostics as a PhD and an Associate…

Uniogen has been featured in Finland’s national public broadcasting company news for developing a blood test that could significantly speed…

Uniogen’s cancer diagnostic platform is based on research conducted and published at the University of Turku. Studies show that the…

Uniogen has achieved a remarkable milestone by receiving the esteemed Seal of Excellence from the European Innovation Council (EIC). This…

Detecting ovarian cancer early has always been challenging, but Uniogen’s test under development, is changing that. Dive in to see…

Specialised in the diagnostics of infectious and cancer diseases, Uniogen is currently developing, among other things, a test for detecting…